Targeted Photodynamic Therapy for Skin Cancer

Article

Video demonstration from a University College London postdoc fellow on the use of laser treatment for skin tumors that does not scar or damage the skin.

What can a bear, food coloring and a laser teach us about cutting-edge treatment for tumors? Dr Martin Austwick, postdoc research fellow at the University College London National Medical Laser Centre, demonstrates how the NMLC is using laser treatment (targeted photodynamic therapy) for skin tumors without scarring or significant damage to the skin.

Visit the NMLC website to learn more about the research being conducted there.

Related Videos
Connective Tissue Disease Brings Dermatology & Rheumatology Together
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.